Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Research roundup: Gender differences in health spending; How the states could fare under the new law; Increased Medicare premiums

Research roundup: Gender differences in health spending; How the states could fare under the new law; Increased Medicare premiums

Walgreens partners with HHS to provide over $10M worth of flu shots for people without adequate health insurance

Walgreens partners with HHS to provide over $10M worth of flu shots for people without adequate health insurance

Scientists suggest targeting ion channels could offer effective pain relief

Scientists suggest targeting ion channels could offer effective pain relief

CF patients with normal to mildly impaired lung function may benefit from new investigational drug

CF patients with normal to mildly impaired lung function may benefit from new investigational drug

Germany has not yet achieved influenza vaccination rates set by WHO

Germany has not yet achieved influenza vaccination rates set by WHO

NIAID renews funding of PRIME to develop mathematical models to study influenza infection

NIAID renews funding of PRIME to develop mathematical models to study influenza infection

Ischemic stroke patients at substantial risk once leaving the hospital: Study

Ischemic stroke patients at substantial risk once leaving the hospital: Study

Prions responsible for BSE can survive in new host environment

Prions responsible for BSE can survive in new host environment

First comprehensive guide to hospital emergency preparedness exercise development

First comprehensive guide to hospital emergency preparedness exercise development

Iowa moves forward on health exchange; Texas medical school highlights geriatrics; Concerns grow about prisoners' mental health needs

Iowa moves forward on health exchange; Texas medical school highlights geriatrics; Concerns grow about prisoners' mental health needs

Accelr8 reports $466,362 net sales revenue for first fiscal quarter ended October 31, 2010

Accelr8 reports $466,362 net sales revenue for first fiscal quarter ended October 31, 2010

Rite Aid third quarter net loss decreases to $79.1 million

Rite Aid third quarter net loss decreases to $79.1 million

Adeona expands and enhances zinc-based product candidate portfolio

Adeona expands and enhances zinc-based product candidate portfolio

Study finds occurrence of infection following surgical procedures

Study finds occurrence of infection following surgical procedures

Study confirms Carrageenan as effective antiviral against H1N1 influenza strain

Study confirms Carrageenan as effective antiviral against H1N1 influenza strain

New nanotechnology based technique to detect pneumonia within minutes

New nanotechnology based technique to detect pneumonia within minutes

Plasma technology safe, effective alternative to antibiotics to treat multi-drug resistant infections

Plasma technology safe, effective alternative to antibiotics to treat multi-drug resistant infections

Over expression of transcription factor improves neurological function in HD transgenic mice models

Over expression of transcription factor improves neurological function in HD transgenic mice models

Unique device eliminates cold and flu germs in eco-friendly way

Unique device eliminates cold and flu germs in eco-friendly way

DBS targets same class of neuronal cells that respond to physical exercise and drug Prozac

DBS targets same class of neuronal cells that respond to physical exercise and drug Prozac

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.